immunotherapy

You have access
Synchronous Basal Cell Carcinoma and Squamous Cell Carcinoma of Nasal Vestibule With Novel Unique Variants Identified by Whole-exome Sequencing
IDA GHLICHLOO, ZHONGBO JIN, RUOHAO FAN, CAILI TONG, PETR STAROSTIK, JEREMY R. CHIEN and JINPING LAI

In Vivo January 2022, 36 (1) 251-257; DOI: https://doi.org/10.21873/invivo.12698
You have access
Significance of Glasgow Prognostic Scores in NSCLC Patients Treated With Immunotherapy After Platinum-based Cytotoxic Chemotherapy
HYE SEON KANG, AH YOUNG SHIN, CHANG DONG YEO, SUNG KYOUNG KIM, CHAN KWON PARK, JU SANG KIM, SEUNG JOON KIM, SANG HAAK LEE and JIN WOO KIM

In Vivo November 2021, 35 (6) 3423-3430; DOI: https://doi.org/10.21873/invivo.12642
You have access
Severe Skin Disorders Due to Sorafenib Use After Nivolumab Treatment in Renal Cell Carcinoma Patients
HIROYOSHI KOIDE, SATOSHI NODA, TETSUYA YOSHIDA, SUSUMU KAGEYAMA, KAZUYA TERAMURA, TAKESHI KATO, AKIHIRO KAWAUCHI, NORIKI FUJIMOTO and TOMOHIRO TERADA

In Vivo September 2021, 35 (5) 2969-2974; DOI: https://doi.org/10.21873/invivo.12591
You have access
Clinical Significance of Composition Changes in T-cell Subpopulations After Chemotherapy in Patients With Gastric Cancer
MIN-KYUNG YEO, PUREUM SUN, CHAEUK CHUNG, JAE HO PARK, SUN HYUNG KANG, HEE SEOK MOON, JAE KYU SUNG, HYUN YONG JEONG and JU SEOK KIM

In Vivo July 2021, 35 (4) 2417-2424; DOI: https://doi.org/10.21873/invivo.12519
You have access
Efficacy of Cabozantinib in Metastatic Papillary Renal Cell Carcinoma Following Ineffective Treatment With Initial Therapy of Nivolumab and Ipilimumab
HIDEKAZU TACHIBANA, YUDAI ISHIYAMA, MAKI YOSHINO, KAORI YAMASHITA, DAISUKE TOKI and TSUNENORI KONDO

In Vivo May 2021, 35 (3) 1743-1747; DOI: https://doi.org/10.21873/invivo.12433
You have access
Granulocyte Colony-stimulating Factor Producing Oropharyngeal Squamous Cell Carcinoma
GREGORY SCHURMANN, MARTIN ZWEIFEL, ROLAND GIGER, TILMAN T. RAU, SARAH VINZENS, MATTHIAS S. DETTMER and YOJENA KURIAN

In Vivo May 2021, 35 (3) 1785-1790; DOI: https://doi.org/10.21873/invivo.12438
You have access
Long-term Response After Stopping Immunotherapy in a Patient With Metastatic Renal Cancer
BOGDAN HAINEALA, ANCA ZGURA, CAMELIA DIACONU, CLAUDIA MEHEDINTU, XENIA BACINSCHI and RODICA MARICELA ANGHEL

In Vivo May 2021, 35 (3) 1805-1810; DOI: https://doi.org/10.21873/invivo.12441
You have access
Lung Cancer, Covid-19 Infections and Chemotherapy
BOGDAN HAINEALA, ANCA ZGURA, DUMITRU CRISTINEL BADIU, LAURA ILIESCU, RODICA MARICELA ANGHEL and XENIA ELENA BACINSCHI

In Vivo May 2021, 35 (3) 1877-1880; DOI: https://doi.org/10.21873/invivo.12450
You have access
Micropapillary Bladder Cancer Metastatic to the Breast: A Case Report and Brief Literature Review
ELENA LIEVORE, LETTERIO RUNZA, MICHELE GHIDINI, BARBARA GALASSI, ANDREA GALLIOLI, CAROLINA BEBI, LUCA BOERI, CONCETTA BLUNDO, CLAUDIA FRANCESCA ROSSI, FABRIZIO LONGO, GIANCARLO ALBO, EMANUELE MONTANARI and ELISA DE LORENZIS

In Vivo January 2021, 35 (1) 453-459; DOI: https://doi.org/10.21873/invivo.12278
You have access
Using Image-guided Intensity-modulated Radiotherapy on Patients With Head and Neck Soft-tissue Sarcoma
KHALED ELSAYAD, DENISE STOCKMANN, MOHAMMED CHANNAOUI, SERGIU SCOBIOALA, ANETA GRAJDA, HENDRIK BERSSENBRÜGGE, SEBASTIAN HUSS, CHRISTOS MOUSTAKIS, UWE HAVERKAMP, JOHANNES KLEINHEINZ, GEORG LENZ, EVA WARDELMANN and HANS THEODOR EICH

In Vivo July 2019, 33 (4) 1293-1300; DOI: https://doi.org/10.21873/invivo.11602

Main menu

User menu

Search

immunotherapy

Pages